Beximco Pharmaceuticals Limited reported earnings results for the full year ended June 30, 2021. For the full year, the company reported sales was BDT 29,493.57 million compared to BDT 25,611.95 million a year ago. Net income was BDT 5,127.69 million compared to BDT 3,514.69 million a year ago. Basic earnings per share from continuing operations was BDT 11.49 compared to BDT 7.88 a year ago.